Posted on February 2nd, 2012 by
Researchers from the University of Minnesota in Minneapolis and Mayo Clinic in Rochester, Minn., are another step closer to developing a drug to combat fungal infections — one of the major problems confronting patients with compromised immune systems. The Minnesota Partnership for Biotechnology and Medical Genomics has awarded Mayo biochemist Zhiguo Zhang, Ph.D., and University medicinal chemist Michael Walters, Ph.D., a commercialization grant of $621,934 for the first year of a two-year period. The research team will use the grant for additional studies that will move their drug discovery toward the marketplace.
Tags: biochemistry, compromised immune systems, fungal infections, Genomics, Mayo Clinic Rochester, Michael Walters, Research, The Minnesota Partnership for Biotechnology and Medical Genomics, University of Minnesota, Zhiguo Zhang
You must be logged-in to the site to post a comment.